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Abstract—Stress echocardiography is an important screening
test for coronary artery disease. Currently, cardiologists rely
on visual analysis of left ventricular (LV) wall motion
abnormalities, which is subjective and qualitative. We
previously used ﬁnite-element models of the regionally
ischemic left ventricle to develop a wall motion measure,
3DFS, for predicting ischemic region size and location from
real-time 3D echocardiography (RT3DE). The purpose of
this study was to validate these methods against regional
blood ﬂow measurements during regional ischemia and to
compare the accuracy of our methods to the current state of
the art, visual scoring by trained cardiologists. We acquired
RT3DE images during 20 brief (<2 min) coronary occlu-
sions in dogs and determined ischemic region size and
location by microsphere-based measurement of regional
perfusion. We identiﬁed regions of abnormal wall motion
using 3DFS and by blinded visual scoring. 3DFS predicted
ischemic region size well (correlation r2 = 0.64 against
microspheres, p< 0.0001), reducing error by more than half
compared to visual scoring (8 ± 9% vs. 19 ± 14%,
p< 0.05), while localizing the ischemic region with equal
accuracy. We conclude that 3DFS is an objective, quantita-
tive measure of wall motion that localizes acutely ischemic
regions as accurately as wall motion scoring while providing
superior quantiﬁcation of ischemic region size.
Keywords—Cardiac mechanics, Coronary artery disease,
Echocardiography, Ischemia, Regional blood ﬂow.
INTRODUCTION
Analysis of left ventricular regional wall motion
during stress echocardiography has proved to be a
useful predictor of coronary artery disease2,22,26,27 and
clinical prognosis.3,9,17,19,33 Visual analysis provides
little quantitative information, is dependent on the
level of experience of the observer,23,29 and is subject to
high inter-observer variability.8 Quantitative analysis
of cardiac images provides a more objective and
accurate approach to diagnosis16; unfortunately,
quantitative analysis of left ventricular wall motion has
been limited by technical issues, particularly the well-
known problem of centroid deﬁnition.21,31
Real-time three-dimensional echocardiography
(RT3DE) is well suited for quantiﬁcation of LV vol-
ume, mass, and function,5–7,10,14,15,20,25,28,32 and for
identifying regional wall motion abnormalities during
exercise or pharmacological stress that indicate the
presence of coronary artery disease.1,18,24,30,34 RT3DE
can be obtained quickly during the critical time period
after exercise before the heart rate drops, yet provides
complete LV visualization. The wealth of information
contained in such fully four-dimensional (3D plus
time) cardiac images will not beneﬁt clinical practice,
however, until clinically useful quantitative informa-
tion can be extracted from the datasets and presented
in a simple and straightforward way within a few
minutes. We previously utilized ﬁnite-element models
of the regionally ischemic left ventricle to develop
methods for quantifying and displaying LV wall
motion and for estimating the size and location of an
ischemic region based on changes in wall motion from
baseline.11 The purpose of this study was to validate
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these methods against regional blood ﬂow measure-
ments during regional ischemia and to compare the
accuracy of our methods to the current state of the art,
visual wall motion scoring by trained cardiologists.
METHODS
Experimental Protocol
This experiment was performed under a research
protocol approved by Columbia University’s Institu-
tional Animal Care and Use Committee. Anesthesia
was induced with propofol (4–8 mg/kg i.v.) in ﬁve dogs
with an average body weight of 25 ± 2.5 kg. The dogs
were intubated and anesthesia was maintained using
inhaled isoﬂurane (1.5–2.5%). Two micromanometer-
tipped pressure catheters (Millar Instruments, Hous-
ton, TX) were inserted through the right and left car-
otid arteries and positioned to measure aortic and left
ventricular pressures. A lateral thoracotomy was per-
formed and the pericardium was opened and sutured
to the chest wall to expose and support the left ven-
tricle. Sutures were placed around the left anterior
descending (LAD) and left circumﬂex (LCx) coronary
arteries or their branches at proximal and distal sites.
Baseline apical RT3D echocardiograms were
acquired using a Philips iE33 ultrasound system (Phi-
lips Medical Systems, Andover, MA). A silicone gel
standoﬀ (Aquaﬂex, Parker Laboratories, Fairﬁeld, NJ)
was placed between the ultrasound probe and the apex
of the heart. Prior to the ﬁrst occlusion, baseline
hemodynamic data were recorded while baseline
microspheres were injected into a left atrial catheter
and reference blood samples were taken from a cath-
eter positioned in the descending aorta. Distal LCx and
LAD occlusions were performed in random order,
followed by proximal occlusions. RT3DE images were
acquired immediately prior to the occlusion and after
60–90 s of occlusion. Just prior to two minutes of
occlusion, the suture was released from the artery and
the dog was allowed to recover for at least 10 min.
Prior to each subsequent occlusion, intermediate
baseline images and hemodynamic data were obtained.
At the conclusion of the experiment, dogs were
euthanized by overdose injection of pentobarbital
sodium (98–118 mg/kg) and phenytoin (12–15 mg/kg).
Assessment of Regional Myocardial Blood Flow
At baseline and during each occlusion, colored
microspheres (Dye-Trak, Triton Technology Inc., San
Diego, CA, 6 million spheres in 2 mL) were injected
into the left atrial catheter and blood was sampled
from the aortic catheter (7 mL/min for 2 min) to allow
measurement of regional blood ﬂow. After each
experiment, the heart was removed and sectioned into
60 blocks (Fig. 1) and regional myocardial blood ﬂow
was determined for each block using standard methods
for quantiﬁcation of colored microspheres.13 The
ischemic tissue fraction was calculated as the fraction
of myocardial segments with 50% or more reduction in
blood ﬂow compared to remote nonischemic regions in
the basal septum. Regional blood ﬂow was displayed
on either a circumferential polar map (Fig. 1c) or a
Hammer projection map (Fig. 1d), with ischemic
regions shaded gray (50–75% reduction) or black
(>75% reduction). The Hammer map is created by
opening the LV along the mid-septum and displaying it
in 2D using an area-preserving projection. This map
provides a true representation of the surface area of the
LV12; for example, regions at the base of the LV are
shown in the correct scale on the Hammer map, while
the basal regions occupy more area than equally sized
mid-ventricular or apical regions on the circumferen-
tial polar map.
Quantitative Wall Motion Analysis
The RT3D echocardiograms were exported to CD
and segmented using Tomtec 4D LV-Analysis software
version 2.0 (Tomtec Imaging Systems, Unterschleiss-
heim, Germany). With three initial contours drawn by
the user, this software semi-automatically detects the
LV endocardial border. Manual editing of the endo-
cardial border was required. The ﬁnal endocardial
surface data were exported and analyzed using custom
software written in Matlab (Mathworks, Natick, MA).
The endocardial data were transformed into a cardiac
coordinate system using three anatomical landmarks
selected at end diastole and end systole: the apex, base
and middle of the septum. This cardiac coordinate
system translates and rotates with the heart, with axes
directed parallel to the base-apex axis (x1), through the
mid-septum (x2), and through the posterior wall (x3)
from an origin located 1/3 of the distance from the
base to the apex along the LV long axis.
Surfaces were ﬁt through the data in prolate sphe-
roidal coordinates as previously described, providing a
compact mathematical representation of the LV
(Fig. 2).11 Brieﬂy, in this elliptical coordinate system, l
represents a longitudinal angular coordinate, h a cir-
cumferential angular coordinate, and k = k(l, h) a
coordinate along an arc from the central axis, roughly
analogous to a radius in spherical coordinates. The
focal length of the coordinate system was set to (2/3 of
the base-apex distance)/cosh(1) to scale the ﬁtting
problem, and data points were projected along lines of
constant l and h onto an undeformed ellipsoidal mesh
(k = 1) composed of 64 bicubic Hermite elements
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FIGURE 1. Blood flow analysis methods demonstrated for proximal LAD occlusion. (a) Baseline and occlusion blood flow levels
measured from colored microspheres in 60 blocks of myocardium. (b) Diagram showing location of myocardial tissue blocks.
(c) Circumferential polar map displaying 50–75% reduction in blood flow from baseline in gray and >75% reduction in black.
(d) A Hammer map of regional blood flow for the same example.
FIGURE 2. Wall motion analysis methods demonstrated for one dog during distal LCx occlusion. (a) Apical 2 chamber view of the
3D echocardiogram at end diastole (ED) and at end systole (ES); there is little motion in the inferior wall from ED to ES. (b) Data
points outlining the left ventricular endocardial border at ED and ES as exported from Tomtec. (c) Surfaces fitted through the data
to provide a compact representation of the left ventricle. (d) Endocardial surfaces (top) at ED (wireframe) and at ES (solid surface)
and three-dimensional fractional shortening (3DFS) displayed on a Hammer projection map (bottom) confirm reduced motion in the
inferior wall (white 5 normal, 3DFS > 25%; light gray 5 hypokinesis, 3DFS: 5–25%; dark gray 5 akinesis, 3DFS: 25% to 5%;
black 5 dyskinesis, 3DFS<25%). In this open-chest anesthetized dog, much of the LV is hypokinetic even outside the ischemic
region.
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(8 circumferential and 8 longitudinal). This projection
converted the ﬁtting problem from 3D to 1D, allowing
the surface to be ﬁtted to the points by minimizing the
least squares error in k.
LV cavity volume was computed as the volume
enclosed by the ﬁtted surface. Three-dimensional
fractional shortening (3DFS) was computed by com-
paring the position of the endocardial surface as
reﬂected in the prolate spheroidal coordinate k at
end diastole (ED) and end systole (ES): 3DFS =
(kED  kES)/kED.11 To account for reduced baseline
function present in open-chest, anesthetized animals,
3DFS measured during each occlusion was subtracted
from that measured at the preceding baseline. This
measurement, D3DFS, was deﬁned as abnormal if
there was a 10% or greater reduction in 3DFS from
baseline. D3DFS was displayed using a Hammer pro-
jection map, with normal D3DFS shaded white and
abnormal D3DFS shaded gray (10–20%) or black
(>20%). The abnormal area fraction (AAF) was
computed as the fraction of the surface area of the LV
with abnormal wall motion.
Visual Wall Motion Analysis
Wall motion scoring was performed on standard 2D
views selected from the 3D dataset by two trained car-
diologists blinded to the experimental condition, using a
16-segment model.16 We used the scoring system rec-
ommended by the American Society of Echocardiog-
raphy (ASE)—normal or hyperkinesis 1, hypokinesis 2,
akinesis 3, dyskinesis 4—and scored each segment in 2
views per ASE guidelines.16 In most cases, the scores
from the two views agreed; in the remaining cases we
averaged the scores from the two views to obtain a ﬁnal
score for the segment. To account for depressed baseline
function in the open-chest dogs, the change in visual
scores from baseline was calculated by subtracting the
wall motion scores from the preceding baseline image.
LV segments with no reduction in wall motion scores
were displayed as white and segments with reduced
scores from baseline were shaded gray (1) or black
(2) on Hammer projection or circumferential polar
maps. The AAFwas computed as the fraction of the LV
segments with reduced wall motion scores.
Evaluation of Predicted Ischemic Region Size and
Location
In order to test the ability of D3DFS and wall
motion scoring to predict ischemic region size, we
examined the correlation between the AAF determined
by D3DFS or segment scoring and the ischemic tissue
fraction quantiﬁed from colored microspheres, as well
as the absolute error in predicting ischemic region size
for each occlusion. To test the accuracy of predictions
of ischemic region location, we compared the fraction
of the endocardial surface that was correctly classiﬁed
as ischemic or non-ischemic based on D3DFS or visual
scoring. D3DFS, visual scores, and blood ﬂow levels
were divided into normal and abnormal (D3DFS<
0.1, change in visual score >0, and 50% or more
reduction in blood ﬂow) and were compared at
>40,000 points on the LV endocardial surface. Each
point was classiﬁed as true positive (TP), true negative
(TN), false positive (FP) or false negative (FN).
The fraction of the LV surface area with an incorrect
prediction was calculated for each occlusion as
(FP + FN)/total area.
Statistical Analysis
All values are reported as mean ± SD. Linear
regressions of AAF computed from D3DFS or wall
motion scores against the size of ischemic region as
determined by colored microspheres were performed
using GraphPad InStat (GraphPad Software, San
Diego, CA). Changes in hemodynamic variables were
assessed using one-way ANOVA with Dunnett post-
tests where appropriate to compare all values to
baseline. The absolute error in prediction of ischemic
region size and location for D3DFS and each cardiol-
ogist were compared using repeated measures ANOVA
with Bonferroni-corrected post-tests between D3DFS
and each cardiologist.
RESULTS
A total of 20 transient occlusions (<2 min) were
performed, four occlusions in each of the ﬁve dogs
studied. One distal LAD occlusion was excluded from
further analysis because the baseline 3D image imme-
diately preceding that occlusion was of poor quality; the
other nineteen occlusions had satisfactory 3D image
quality. Hemodynamic data obtained at baseline and
during the occlusions are listed in Table 1. As expected,
coronary occlusion signiﬁcantly depressed left ventric-
ular function (end-systolic pressure, p< 0.05; ejection
fraction, p< 0.01). Hemodynamic data also conﬁrmed
a reasonable degree of return to baseline between
occlusions (data not shown): ANOVA across the four
baseline runs acquired over the course of the study (one
before each occlusion) showed no signiﬁcant trends with
time for any of the parameters in Table 1.
Assessment of Regional Myocardial Blood Flow
Regional blood ﬂow quantiﬁcation for a typical
proximal LAD occlusion is shown in Fig. 1. Blood
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ﬂow levels were severely reduced in the anterior wall as
shown in the graph of blood ﬂow levels (Fig. 1a) and in
the blood ﬂow maps (Figs. 1c and 1d). Microsphere
analysis revealed ischemia (perfusion< 50% of con-
trol segments) in 38% of the left ventricular wall for
this example. Across all occlusions studied, the range
of ischemic region sizes by microsphere analysis was
0–43%, with a mean size of 6 ± 6% for distal LAD
occlusions, 27 ± 7% for proximal LAD occlusions,
25 ± 14% for distal LCx occlusions, and 40 ± 3% for
proximal LCx occlusions.
Quantitative and Visual Wall Motion Analysis
Figure 3 illustrates the results of quantitative wall
motion analysis and visual scoring for distal left cir-
cumﬂex occlusion in one dog. During this occlusion,
blood ﬂow was severely reduced in the posterolateral
wall (Fig. 3a, gray and black regions) in an area rep-
resenting 33% of the left ventricle by mass. Wall
motion was reduced in the posterolateral wall, as
shown in the map of D3DFS (Fig. 3b, gray and black
regions); the quantitative analysis revealed >10%
reduction in 3DFS on 34% of the LV endocardial
surface, providing excellent quantitative agreement
with blood ﬂow data. Visual wall motion scoring re-
sults from both cardiologists showed reduced scores
relative to baseline in the posterolateral wall but also in
other segments (Figs. 3c–3f); in this case wall motion
scoring signiﬁcantly overestimated ischemic region
size, placing it between 50% (8/16 segments) and 56%
(9/16) of the left ventricle.
Prediction of Ischemic Region Size and Location
Our previously published ﬁnite element simulations
predicted that the fraction of the endocardial surface
displaying abnormal 3DFS should be linearly related
TABLE 1. Hemodynamic parameters at baseline and during transient coronary occlusion of the coronary arteries indicated.
Variable Baseline Distal LAD Proximal LAD Distal LCx Proximal LCx
LV EDP (mmHg) 9.9 ± 4.3 11.4 ± 3.2 13.9 ± 2.0 13.6 ± 2.9 13.6 ± 2.1
LV ESP (mmHg) 77.6 ± 6.6 71.0 ± 6.0 57.8 ± 8.9* 63.7 ± 9.7* 57.9 ± 4.2*
HR (bpm) 95 ± 5 90 ± 4 91 ± 7 95 ± 9 93 ± 10
EDV (mL) 46.3 ± 6.2 47.1 ± 4.2 52.2 ± 8.8 52.5 ± 2.4 51.1 ± 9.2
ESV (mL) 24.6 ± 3.4 27.9 ± 2.9 35.5 ± 7.0* 32.9 ± 2.4 34.2 ± 7.2*
EF (%) 47 ± 3 41 ± 2 32 ± 4* 37 ± 4* 33 ± 5*
CO (L/min) 2.1 ± 0.3 1.7 ± 0.2 1.5 ± 0.3 1.9 ± 0.3 1.6 ± 0.4
Values are mean ± SD (n = 4 for baseline and distal LAD, 5 for other occlusions). LV = left ventricle; EDP = end-diastolic pressure;
ESP = end-systolic pressure; HR = heart rate; EDV = end-diastolic volume; ESV = end-systolic volume; EF = ejection fraction;
CO = cardiac output.
* Indicates significantly different from baseline by ANOVA and Dunnett post-test.
FIGURE 3. Analysis of data from one dog with distal left
circumflex occlusion. (a) Map of regional blood flow distri-
bution; regions with normal blood flow are shown in white
and regions with more than 50% reduction in blood flow from
baseline are shaded gray and black. (b) Map of changes in
3DFS from baseline; regions with more than 10% reduction in
3DFS from baseline are shaded gray and black. (c–f) Changes
in wall motion scores from baseline by two trained cardiolo-
gists are displayed on Hammer projection maps (c, d) and
polar circumferential maps (e, f); white indicates no change
from baseline, gray and black regions with reduced wall
motion scores from baseline. S 5 septum; A 5 anterior;
L 5 lateral; P 5 posterior.
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to the fraction of myocardium that is ischemic, above a
threshold ischemic region size of about 7% of the left
ventricle11; data from those simulations are re-plotted
in Fig. 4a for comparison with the experimental results
reported here. The fraction of the endocardium with
more than 10% reduction in 3DFS from baseline
(D3DFS<0.10) correlated well with ischemic tissue
fraction as measured by colored microspheres
(Fig. 4b), and the regression line had a slope near 1
(r2 = 0.64, slope = 0.90, p< 0.0001). Consistent with
model predictions, three of the four smallest occlusions
produced little wall motion abnormality. The fraction
of endocardial segments with reduced wall motion
scores from visual analysis also correlated with the
ischemic tissue fraction (Figs. 4c and 4d; r2 = 0.41,
slope = 0.89, p = 0.002, and r2 = 0.61, slope = 1.73,
p< 0.0001). However, the slope and intercept of the
regression lines for the two cardiologists were very
different.
While quantitative analysis and visual scoring both
produced ischemic region size estimates that correlated
with ischemic tissue fraction, the size estimates derived
from quantitative analysis were much more accurate
(Fig. 5, dark gray bars), reducing error by more than
half (3DFS error 0.079 ± 0.087, cardiologist 1
0.188 ± 0.127, cardiologist 2 0.197 ± 0.155, p< 0.05
for 3DFS vs. both cardiologists). D3DFS and visual
scoring showed similar accuracy in predicting ischemic
region location (Fig. 5, light gray bars, p< 0.05 for
3DFS vs. cardiologist 1 only).
FIGURE 4. Ischemic region size prediction. (a) Relationship between size of wall motion abnormality identified by 3DFS
(abnormal area fraction, AF) and simulated ischemic region size in model analysis reported previously in Herz et al.11; dotted line
shows line of identity (‘perfect’ prediction). (b) Analysis of 19 brief experimental coronary occlusions in open-chest anesthetized
dogs confirmed a close relationship between size of wall motion abnormality identified by 3DFS and true ischemic region size by
microsphere-based blood flow measurement. (c, d) The predictions of ischemic region size based on the fraction of the endo-
cardial surface with reduced wall motion scores assigned by two cardiologists also correlated significantly with ischemic region
size assessed by microspheres.
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DISCUSSION
Clinical management of cardiac patients relies
heavily on quantitative measures such as blood pres-
sure, cholesterol levels, and ejection fraction; such
measures are essential for risk stratiﬁcation and in
developing treatment guidelines.While ejection fraction
is a valuable quantitative measure of global left ven-
tricular (LV) function, standard echocardiographic
assessment of regional LV function (wall motion anal-
ysis) remains qualitative, primarily because quantitative
analysis of LVwall motion has been limited by technical
issues such as the well-known problem of centroid def-
inition.21,31 The overall goal of our work is therefore to
develop robust methods for quantiﬁcation of LV wall
motion. The purpose of the present study was to test a
novel measure of wall motion, 3D fractional shortening
(3DFS), which we developed for the speciﬁc purpose of
predicting the size of an acutely ischemic region. We
validated 3DFS-based predictions of the size and loca-
tion of experimentally induced ischemic regions against
regional blood ﬂowmeasurements. The change in 3DFS
from baseline (D3DFS) predicted ischemic region size
better than visual scoring by trained cardiologists, while
identifying the location of ischemic regions with the
same accuracy as visual scoring.
Prediction of Ischemic Region Size
We initially designed and tested 3DFS on computer
simulations of acute ischemia with the goal of
predicting ischemic region size.11 In these computa-
tional modeling studies, the fraction of the endocardial
surface displaying abnormal 3DFS was linearly related
to the fraction of myocardium that was ischemic,
suggesting that 3DFS could be used to estimate the size
of acutely ischemic regions (Fig. 4a).11 In the present
study, we conﬁrmed that D3DFS-predicted ischemic
region size correlated well with true ischemic region
size across a range of experimental coronary occlusions
(Fig. 4b), as predicted by our original computer sim-
ulation.11 Our computer simulation also predicted an
inability to detect very small ischemic regions due to
tethering to adjacent non-ischemic myocardium, a
ﬁnding conﬁrmed in three small occlusions performed
here. This may reﬂect a fundamental limitation of wall
motion analysis; in our computer models, we could
detect smaller ischemic regions using circumferential
strain but not using wall motion or wall thickening.
When compared to the current state of the art, visual
scoring by trained cardiologists, D3DFS provided a
more accurate estimate of ischemic region size (Fig. 5).
Prediction of Ischemic Region Location
The ability to predict the location of the ischemic
region was similar among D3DFS and two trained
cardiologists. The error in prediction of ischemic
region location was higher than the error in prediction
of ischemic region size (Fig. 5); this is primarily
because the measure of error for ischemic region
location was particularly stringent. For example, a
misregistration of the predicted and true ischemic
region will produce false-negative classiﬁcation of the
endocardial surface on one side of the ischemic region
and false-positive classiﬁcation on the opposite side,
essentially counting the error twice.
Beneﬁts of 3D Analysis
The use of RT3DE oﬀers several advantages over
2D imaging. For example, the reduced imaging time1,18
is crucial for exercise stress echocardiography, when
the entire heart must be scanned rapidly at peak heart
rate. Our novel technique takes advantage of the entire
3D geometry of the heart visible in RT3DE as opposed
to individual slices through the image, allowing for
continuous measurement of wall motion throughout
the entire LV rather than at a few discrete locations.
However, the most important advantage of RT3D for
this work was the fact that the entire LV is visible in
the image, enabling new solutions to the problem of
deﬁning a centroid as a reference system for wall
motion analysis.21,31 Using anatomical landmarks that
are less affected by regional wall motion abnormalities
than a centroid, such as the center of the mitral valve
FIGURE 5. Comparison of error in predicting ischemic
region size and location from D3DFS vs. wall motion scoring.
Quantitative analysis using D3DFS provided a significant
reduction in error for predicting ischemic region size com-
pared to wall motion scoring by both cardiologists and for
localizing the ischemic region compared to wall motion
scoring by one of the two cardiologists. * p< 0.05 compared to
3DFS; error bars indicate SD.
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oriﬁce, to register the position of the endocardial surface
through time has been shown to be more reliable
than selecting a centroid.4
Adjustment for Reduced Baseline Function
In this experiment, opening the chest and adminis-
tering anesthesia resulted in depressed baseline func-
tion. To account for depressed baseline function, we
subtracted wall motion measured in preceding baseline
images from that obtained in occlusion images. In
addition to accounting for reduced baseline function in
this experiment, D3DFS provides a mathematical
approach for comparing subsequent image datasets,
and is capable of identifying subtle changes that might
go unnoticed when viewing images side by side. The
ability to account for reduced baseline function is
clinically relevant for patients with heart failure or
those who have had previous infarction. Our approach
may also prove useful for evaluating follow-up studies
and for comparing images obtained at rest and stress
during stress echocardiography.
Analysis Time
Oﬄine image analysis required approximately
15 min to trace the endocardial border for each data
set and an additional 2 min for computing D3DFS.
Visual wall motion scoring took approximately 10–
15 min for each data set. Therefore, routine compu-
tation of 3DFS is already practical with a similar time
investment to visual scoring. It is important to note
that for assessment of ischemic region size as in this
study, only two images (end diastole and end systole)
must be traced. Other applications of quantitative wall
motion analysis that are of clinical interest, such as the
measurement of mechanical synchrony, require data
from the full cardiac cycle, doubling the time required
for editing the endocardial border using present soft-
ware. As 3D image quality improves and software
for detecting the endocardial border becomes more
reﬁned, the amount of time for image analysis will
continue to decrease.
Limitations and Sources of Error
The largest sources of error and variability in our
quantitative analysis are manual tracing of endocardial
contours and selection of anatomic landmarks. In a
preliminary study on 20 clinical RT3D images, we
examined the repeatability of these two aspects as well
as the sensitivity of our analysis to landmark selection.
Repeat tracing of the end-diastolic endocardial surface
by an experienced user after an average delay of
6 months resulted in an RMS diﬀerence in lambda of
9.4%. Repeat selection of landmarks after 6 months
resulted in an average shift in the apical and basal
landmarks of 4.6 and 5.3 mm (5.8 and 6.8% of LV
long axis length) respectively. These landmark shifts
translated to an RMS diﬀerence in lambda of 19.5%,
suggesting that controlling variability in landmark
selection should be our primary focus moving forward.
Sensitivity analysis showed that our endocardial sur-
face ﬁts are more sensitive to shifts in the apical than
basal landmark, which may increase variability in the
setting of apical bulging or distortion. Future studies
will include a full examination of inter-observer vari-
ability on a large clinical dataset. At present, we note
only that the success of our analysis in predicting
ischemic region size in this study suggests that an
experienced user can select landmarks and identify the
endocardial border with suﬃcient accuracy to provide
useful quantitative information using our approach,
even in situations where the ischemic region involves
the left ventricular apex.
In this study, we focused on testing D3DFS to
determine its capability to predict the size and location
of ischemic regions. However, ischemia was induced
via total occlusion of various coronary arteries, creating
a mismatch between regional oxygen supply and
demand by reducing regional blood ﬂow. In clinical
stress echocardiography, the mismatch between oxygen
supply and demand arises primarily from increasing
demand rather than decreasing supply. Stress echocar-
diography may therefore induce subtler ischemia than
produced in our study. Additional studies are needed to
determine whether the accuracy of our methods for
predicting ischemic region size depends on the severity
of ischemia. We expect that both the D3DFS threshold
used to deﬁne ‘‘abnormal’’ wall motion and the speciﬁc
relationship for predicting ischemic region size based on
the size of the wall motion abnormality are likely to be
diﬀerent in closed chest humans and in the setting of
enhanced overall ejection typical of exercise or dobu-
tamine stress. For example, ischemic regions may
demonstrate smaller increases in 3DFS than surround-
ing healthy myocardium during clinical stress testing, as
opposed to the substantial decreases in 3DFS we
observed during coronary occlusion in this study.
In this experiment, opening the chest and adminis-
tering anesthesia resulted in depressed baseline func-
tion. The depressed baseline may have reduced the
eﬀectiveness of wall motion scoring in detecting
ischemia, since some segments were hypokinetic at
baseline; we attempted to compensate for this by
identifying as ischemic only segments in which wall
motion score worsened from baseline. Four temporary
occlusions were performed in each dog, potentially
altering baseline regional function over the course of
the study. We acquired intermediate baseline images
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and hemodynamic data prior to each occlusion and
found no signiﬁcant change in baseline ejection frac-
tion or end-systolic pressure over the course of the
study. These data suggest that the use of multiple brief
temporary occlusions in each dog, instead of single
occlusions in a much larger number of dogs, was a
reasonable approach that did not strongly aﬀect the
results of this study.
CONCLUSION
The purpose of this study was to test the ability of our
novel measure of wall motion, 3D fractional shortening
(3DFS), to identify the size and location of an experi-
mentally induced ischemic region by validating our
methods against regional blood ﬂow measurements.
Across 19 occlusions with satisfactory image quality, the
fraction of the LVwith depressed 3DFS and the fraction
of segments with reduced visual wall motion scores both
correlated with the microsphere-indicated true ischemic
region size (3DFS r2 = 0.64, cardiologist 1 r2 = 0.44,
cardiologist 2 r2 = 0.67). However, 3DFS predicted
ischemic region size more accurately than wall motion
scoring, reducing error by more than half (3DFS error
0.079 ± 0.087, cardiologist 1 0.188 ± 0.127, cardiolo-
gist 2 0.197 ± 0.155, p< 0.05). 3DFS and wall motion
scoring identiﬁed ischemic region location with equal
accuracy. The methods for wall motion analysis pre-
sented here offer numerous advantages compared to
currently available techniques including quantiﬁcation
of ischemic region size, fully 3D wall motion analysis,
and elimination of the need for deﬁning a centroid. We
conclude that 3DFS is an objective, quantitative mea-
sure of wall motion that localizes acutely ischemic
regions as accurately as visual wall motion scoring while
providing superior quantiﬁcation of ischemic region size.
This quantitative approach to identifying regional
ischemia in three-dimensional images has the potential
to improve clinical screening for coronary artery disease.
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